Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2026-06-13 @ 7:55 PM
Study NCT ID:
NCT03769168
Status:
COMPLETED
Last Update Posted:
2025-10-16
First Post:
2018-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CAIN457F2304E1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None